Bowman & Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-22,769
| Closed | -$2.04M | – | 113 |
|
2025
Q1 | $2.04M | Buy |
22,769
+651
| +3% | +$58.4K | 1% | 28 |
|
2024
Q4 | $2.2M | Sell |
22,118
-1,851
| -8% | -$184K | 1.14% | 22 |
|
2024
Q3 | $2.72M | Buy |
23,969
+2,184
| +10% | +$248K | 1.43% | 19 |
|
2024
Q2 | $2.7M | Buy |
21,785
+2,208
| +11% | +$273K | 1.56% | 18 |
|
2024
Q1 | $2.58M | Sell |
19,577
-560
| -3% | -$73.9K | 1.56% | 17 |
|
2023
Q4 | $2.19M | Buy |
20,137
+1,139
| +6% | +$124K | 1.53% | 15 |
|
2023
Q3 | $1.96M | Buy |
18,998
+1,029
| +6% | +$106K | 1.56% | 15 |
|
2023
Q2 | $2.07M | Buy |
17,969
+896
| +5% | +$103K | 1.57% | 15 |
|
2023
Q1 | $1.82M | Buy |
17,073
+1,886
| +12% | +$201K | 1.33% | 17 |
|
2022
Q4 | $1.68M | Buy |
15,187
+1,087
| +8% | +$121K | 1.31% | 14 |
|
2022
Q3 | $1.21M | Buy |
14,100
+961
| +7% | +$82.7K | 1.1% | 20 |
|
2022
Q2 | $1.2M | Buy |
13,139
+2,314
| +21% | +$211K | 1.05% | 16 |
|
2022
Q1 | $888K | Buy |
10,825
+2,024
| +23% | +$166K | 0.68% | 26 |
|
2021
Q4 | $677K | Buy |
+8,801
| New | +$677K | 0.52% | 36 |
|